Dr Matthew Cranstoun is joining Terrace Eye Centre from September 2019 and is a second-generation ophthalmologist with subspecialist training in Oculoplastics, Orbital and Lacrimal Disease.
Upon graduating from Medicine at the University of Queensland, Dr Cranstoun undertook ophthalmology training in his native Queensland and completed his advanced examinations in 2017. At the completion of his general Ophthalmology training, Dr Cranstoun did further advanced training in cataract and anterior segment surgery, glaucoma, ocular oncology and oculoplastics as the senior registrar at the Mater Hospital, South Brisbane.
In 2018-2019, Dr Cranstoun was awarded a prestigious fellowship with the Terrace Eye Centre’s Professor Timothy Sullivan in Oculoplastics, Lacrimal and Orbital Disease. This world-renowned fellowship included clinical positions at the Royal Brisbane and Women’s Hospital and Queensland Children’s Hospital and involved management of complex adult and paediatric conditions under the guidance of Professor Sullivan, Dr Cranstoun’s friend and mentor.
Dr Cranstoun is actively involved in research and evidenced based care and together with Professor Sullivan, was awarded the Dermot Roden prize for the best Oculoplastics paper presented at the 2018 annual RANZCO scientific meeting. His passion for evidenced based care is demonstrated in his ongoing commitment to research and audit.
Dr Cranstoun is a dedicated and active member of the Royal Australian and New Zealand College of Ophthalmologists and works publicly at the Royal Brisbane and Women’s Hospital as a visiting specialist where he is involved in the teaching of the next generation of Ophthalmologists. He is also an associate lecturer with the University of Queensland medical school.
Dr Cranstoun’s interests include:
• Eyelid disease – malposition, tumours & lesions, ptosis and blepharoplasty (including paediatric ptosis)
• Lacrimal disease – management of the watery eye in adults and children, open and endoscopic DCR, lacrimal bypass surgery
• Orbital Disease – thyroid eye disease, orbital inflammation and tumours, ocular adnexal lymphoma
• Anterior segment oncology